A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients With Advanced Malignancies

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-0180
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Phase I Study of Indoximod in Patients With Advanced Malignancies

Oncotarget
Oncology
2016English

Phase I Trial of FOLFIRI in Combination With Sorafenib and Bevacizumab in Patients With Advanced Gastrointestinal Malignancies.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Age-Stratified Phase I Trial of a Combination of Bortezomib, Gemcitabine, and Liposomal Doxorubicin in Patients With Advanced Malignancies

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2011English

A Phase I Study of Weekly Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies

Oncologist
Cancer ResearchMedicineOncology
2010English

A Phase 1 Study of Oral Ridaforolimus in Pediatric Patients With Advanced Solid Tumors

Oncotarget
Oncology
2016English

A Phase Ib and Pharmacokinetic Trial of Patupilone Combined With Carboplatin in Patients With Advanced Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

A Phase I Trial of MK-0731, a Kinesin Spindle Protein (KSP) Inhibitor, in Patients With Solid Tumors

Investigational New Drugs
OncologyPharmacology
2011English

A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer

Investigational New Drugs
OncologyPharmacology
2014English

Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy